Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony M Buckley

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|November 21, 2018
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human ColonInes B Moura, Anthony M Buckley, Duncan Ewin, et al.
BMC Microbiology|January 4, 2020
Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colonInes B Moura, Charmaine Normington, Duncan Ewin, et al.
Nature Reviews. Microbiology|October 2, 2025
Clostridioides difficile pathogenesis and controlCaroline H Chilton, Virginie Viprey, Charmaine Normington, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In VivoJanet Y Nale, Janice Spencer, Katherine R Hargreaves, et al.
Vaccine|October 27, 2009
Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C. jejuni in poultryAnthony M Buckley, Jinhong Wang, Debra L Hudson, et al.
Science Translational Medicine|September 8, 2017
New class of precision antimicrobials redefines role of <i>Clostridium difficile</i> S-layer in virulence and viabilityJoseph A Kirk, Dana Gebhart, Anthony M Buckley, et al.
Frontiers in Microbiology|June 17, 2022
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut MicrobiotaInes B Moura, Ayman Grada, William Spittal, et al.
Microbial Biotechnology|April 10, 2023
MiGut: A scalable in vitro platform for simulating the human gut microbiome-Development, validation and simulation of antibiotic-induced dysbiosisWilliam A Davis Birch, Ines B Moura, Duncan J Ewin, et al.
Cellular Microbiology|April 14, 2006
The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesisAnthony M Buckley, Mark A Webber, Sue Cooles, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2021
The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infectionAnthony M Buckley, Ines B Moura, James Altringham, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|November 21, 2018
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human ColonInes B Moura, Anthony M Buckley, Duncan Ewin, et al.
BMC Microbiology|January 4, 2020
Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colonInes B Moura, Charmaine Normington, Duncan Ewin, et al.
Nature Reviews. Microbiology|October 2, 2025
Clostridioides difficile pathogenesis and controlCaroline H Chilton, Virginie Viprey, Charmaine Normington, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In VivoJanet Y Nale, Janice Spencer, Katherine R Hargreaves, et al.
Vaccine|October 27, 2009
Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C. jejuni in poultryAnthony M Buckley, Jinhong Wang, Debra L Hudson, et al.
Science Translational Medicine|September 8, 2017
New class of precision antimicrobials redefines role of <i>Clostridium difficile</i> S-layer in virulence and viabilityJoseph A Kirk, Dana Gebhart, Anthony M Buckley, et al.
Frontiers in Microbiology|June 17, 2022
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut MicrobiotaInes B Moura, Ayman Grada, William Spittal, et al.
Microbial Biotechnology|April 10, 2023
MiGut: A scalable in vitro platform for simulating the human gut microbiome-Development, validation and simulation of antibiotic-induced dysbiosisWilliam A Davis Birch, Ines B Moura, Duncan J Ewin, et al.
Cellular Microbiology|April 14, 2006
The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesisAnthony M Buckley, Mark A Webber, Sue Cooles, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2021
The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infectionAnthony M Buckley, Ines B Moura, James Altringham, et al.
Pageof 4